Microfluidics as a Novel Technique for Tuberculosis: From Diagnostics to Drug Discovery

Microfluidics as a Novel Technique for Tuberculosis: From Diagnostics to Drug Discovery

Tuberculosis (TB) remains a global healthcare crisis, with an estimated 5.8 million new cases and 1.5 million deaths in 2020. TB is caused by infection with the major human pathogen <i>Mycobacterium tuberculosis</i>, which is difficult to rapidly diagnose and treat. There is an urgent ne...

Full description

Bibliographic Details
Main Authors: Antonia Molloy, James Harrison, John S. McGrath, Zachary Owen, Clive Smith, Xin Liu, Xin Li, Jonathan A. G. Cox
Format: Article
Language:English
Published: MDPI AG 2021-11-01
Series:Microorganisms
Subjects:
tuberculosis
<i>Mycobacterium</i>
diagnostics
drug discovery
antibiotics
antimicrobial resistance
Online Access:https://www.mdpi.com/2076-2607/9/11/2330

Internet

https://www.mdpi.com/2076-2607/9/11/2330

Similar Items